Patient Name : Ms.

MADHUMITA JANA Collected : 24/Aug/2025 12:26PM

Age/Gender : 36 Y 0 M 0 D /F Received : 24/Aug/2025 06:41PM
UHID/MR No : APJ1.0033103063 Reported : 24/Aug/2025 08:34PM
Visit ID : DPSKOPV26208 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : SALT LAKE,Kolkata

DEPARTMENT OF SEROLOGY
STDS PACKAGE

Test Name Result Unit Bio. Ref. Interval Method

VDRL (RPR) , SERUM NON REACTIVE NON-REACTIVE Slide Flocculation

Comment:
Veneral Disease Research Laboratory (VDRL) test is a non-specific screening test and reactive results must be correlated with supportive clinical, historical and
epidemiological evidence to arrive at a final diagnosis. Titers of 1:8 and above are considered significant. False positives may be seen in a variety of acute and
chronic conditions. It is advisable to confirm diagnosis by TPHA, FTA-Abs, TPI test.
Biological False Positive Results:
(A) Infectious:
1. Bacterial: Scarlet fever, Pneumococcal pneumonia, Bacterial endocarditis, Leprosy, Tuberculosis.
2. Protozoal: Malaria, Trypanosomiasis.
3. Viral: HIV, Measles, Mumps, Viral hepatitis, Chicken Pox, Infectious mononucleosis, etc.
(B) Non-Infectious:
Pregnancy, Advanced cancer, Multiple blood transfusions, Multiple myeloma, Connective tissue disease.
Biological False Negative Results:
May be due to prozone phenomenon. The test must be repeated with higher dilutions of serum, if clinically indicated.
Comparison of RPR, TPHA tests

Test Use Limitations

Biological false positives possible. Repeat
Screening test. Follow-up titres for testing should be done with a specific test
RPR
monitoring response to treatment. like TPHAfor low titres such as 1:1, 1:2 and
1:4.
TPHA More specific than RPR Less sensitive in early syphilis.
RPR : Rising titres are found in active disease and levels subside after successful treatment.
RPR is a simplified alternative to the conventional VDRL test. It has modified VDRL antigen which contains carbon particles. Due to ease of visualisation, the test
is sensitive and the test of choice for serum samples.

Page 1 of 4

SIN No:SE02851426
Patient Name : Ms.MADHUMITA JANA Collected : 24/Aug/2025 12:26PM
Age/Gender : 36 Y 0 M 0 D /F Received : 24/Aug/2025 06:41PM
UHID/MR No : APJ1.0033103063 Reported : 24/Aug/2025 08:34PM
Visit ID : DPSKOPV26208 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : SALT LAKE,Kolkata

DEPARTMENT OF SEROLOGY
STDS PACKAGE

Test Name Result Unit Bio. Ref. Interval Method

HIV I AND II ANTIBODIES , SERUM 0.100 COI <1.0 Non Reactive ECLIA
~>/=1.0 Reactive

Comment:
Conclusion from Testing
Results in COI Units
Algorithm
< 1.0 NON-REACTIVE
≥ 1.0 REACTIVE

​This test uses 4 recombinant antigens derived from HIV-1 core (p24), HIV-1 envelope (env 10 and env13) and HIV-2 envelope (env Al).
These antigens detect antibodies to HIV-1 and antibodies to HIV-2 in the same test.
Reactive results suggest the presence of HIV-1 and/or HIV-2 infection, but it is not diagnostic for HIV infection and should be considered
preliminary. The results from this or any other diagnostic kit should be used and interpreted only in the context of the overall clinical
picture.
A negative test result does not exclude the possibility of exposure to or infection with HIV. Levels of HIV antibodies may be undetectable
in the early stages of infection.

Test Name Result Unit Bio. Ref. Interval Method

HBsAg , SERUM 0.250 IU/mL <0.9:Non-reactive ECLIA
>/=1:Reactive: ≥0.9
<1:Borderline

Comment:
Results in IU/mL Units Conclusion from Testing Algorithm
< 0.90 NON-REACTIVE
≥0.90 - < 1.00 INDETERMINATE
≥1.00 REACTIVE

Interpretation:
• This is a screening assay which detects the first serological marker of Hepatitis B as early as 4-16 weeks after exposure.
• It persists during acute illness and usually disappears 12-20 weeks after onset of symptoms. Persistence of HBsAg for more than 6
months indicates development of carrier state or chronic liver disease
• A negative test result does not exclude with certainty a possible exposure to or an infection with the hepatitis B virus.
• It is recommended that a positive result of HBsAg must be be confirmed using a different enzyme immunoassay kit or by using a
Page 2 of 4

SIN No:SE02851426
Patient Name : Ms.MADHUMITA JANA Collected : 24/Aug/2025 12:26PM
Age/Gender : 36 Y 0 M 0 D /F Received : 24/Aug/2025 06:41PM
UHID/MR No : APJ1.0033103063 Reported : 24/Aug/2025 08:34PM
Visit ID : DPSKOPV26208 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : SALT LAKE,Kolkata

DEPARTMENT OF SEROLOGY
STDS PACKAGE

confirmatory assay based on neutralisation with human anti hepatitis B surface antibody and/or HBV PCR
• Based upon clinical history it may become necessary to test for presence of other markers of hepatitis B virus infection.

Test Name Result Unit Bio. Ref. Interval Method

ANTI HCV , SERUM 0.050 COI <0.9:Non-reactive: ECLIA
>/=1:Reactive: >/=0.9
<1:Borderline

Comment:

Results in COI Units Conclusion from Testing Algorithm

< 0.90 NON-REACTIVE
≥0.90 - < 1.00 INDETERMINATE
≥1.00 REACTIVE

Interpretation:
• This is a Screening assay.HCV Antibodies are usually not detectable during the first 2 months following infection, and they are
usually detectable by the late convalescent stage (>6 months of onset) of infection.
• A positive result indicates the presence of Hepatitis C virus (HCV) – specific IgG antibodies due to past (resolved) or chronic
Hepatitis C. CDC recommendation on anti-HCV testing includes the use of method specific optimal signal-to-cut-off ratio in
interpretation & reporting results. For s/co ratio - between 1 to 6- further supplemental tests are suggested for confirmation, while
s/co ratio > or = 6 associated with 95% or more high probability of being true positive.
• Suggested supplemental test for confirmation are direct detection of HCV RNA by the reverse transcriptase-PCR (RT-PCR)
• An indeterminate result indicates that HCV-specific IgG antibodies may or may not be present.Indeterminate results should be
interpreted along with patient's risk factors for HCV infection and clinical findings. Individuals at risk for HCV infection with
indeterminate results should be retested with an HCV antibody confirmatory test in 1 to 2 months to determine the definitive HCV
antibody status.
• A non-reactive result does not exclude the possibility of exposure to or infection with HCV.Patients with auto-immune liver
diseases, renal disorders may show falsely reactive results.

Page 3 of 4

SIN No:SE02851426
Patient Name : Ms.MADHUMITA JANA Collected : 24/Aug/2025 12:26PM
Age/Gender : 36 Y 0 M 0 D /F Received : 25/Aug/2025 02:33PM
UHID/MR No : APJ1.0033103063 Reported : 25/Aug/2025 03:25PM
Visit ID : DPSKOPV26208 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : SALT LAKE,Kolkata

DEPARTMENT OF SEROLOGY

Test Name Result Unit Bio. Ref. Interval Method

HERPES SIMPLEX VIRUS (HSV) TYPE 1&2 IgM and IgG , SERUM
HERPES SIMPLEX VIRUS 1 & 2 lgM 0.836 index value <0.9 NEGATIVE~0.9 - CLIA
1.1 EQUIVOCAL~>1.1
POSITIVE
HERPES SIMPLEX VIRUS 1 & 2 lgG 10.6 index value <0.9 NEGATIVE~0.9 - CLIA
1.1 EQUIVOCAL~>1.1
POSITIVE
Comment:
.

*** End Of Report ***

Page 4 of 4

SIN No:SE02851822
This test has been performed at Apollo Health and Lifestyle Ltd- Hyderabad.
 Patient Name : Ms.MADHUMITA JANA Collected : 24/Aug/2025 12:26PM
Age/Gender : 36 Y 0 M 0 D /F Received : 25/Aug/2025 02:33PM
UHID/MR No : APJ1.0033103063 Reported : 25/Aug/2025 03:25PM
Visit ID : DPSKOPV26208 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : SALT LAKE,Kolkata

TERMS AND CONDITIONS GOVERNING THIS REPORT

1. Reported results are for information and interpretation of the referring doctor or such other medical professionals, who understand
reporting units, reference ranges and limitation of technologies. Laboratories not be responsible for any interpretation whatsoever
2. This is computer generated medical diagnostics report that has been validated by an Authorized Medical Practitioner/Doctor. The
report does not need physical signature.
3. Partial reproduction of this report is not valid and should not be resorted to draw any conclusion.
4. In the case you are not the intended recipient of this report. Please immediately return the same to the concerned issuing desk. Any
disclosure, copy or distribution of any contents of this report, is unlawful and is strictly prohibited.
5. Results delays may occur due to unforeseen circumstances such as non-availability of kits, equipment breakdown, natural calamities,
IT downtime, logistic delays or any other unavoidable event. For certain tests based on analyte stability, criticality of results and in the
interest of patient for having appropriate medical diagnosis, the same test may be outsourced to other accredited laboratory.
6. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the verifications of
particulars have been confirmed by the patient or his / her representative at the point of generation of said specimen
7. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
8. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies
9. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
10. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only

SIN No:SE02851822
This test has been performed at Apollo Health and Lifestyle Ltd- Hyderabad.